Results 71 to 80 of about 588 (131)
Macrophages as carriers of boron carbide nanoparticles dedicated to boron neutron capture therapy
Background The use of cells as carriers for the delivery of nanoparticles is a promising approach in anticancer therapy, mainly due to their natural properties, such as biocompatibility and non-immunogenicity.
Anna Wróblewska +10 more
doaj +1 more source
This journal retracts the article “Fe3O4 Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy” [...]
Kanat Dukenbayev +13 more
doaj +1 more source
BORON-NEUTRON CAPTURE THERAPY (SLOW NEUTRON CAPTURE THERAPY)
Hiroshi HATANAKA +5 more
openaire +3 more sources
Boron neutron capture therapy of a murine melanoma.
Boron neutron capture therapy has been carried out on BALB/c mice carrying the Harding-Passey melanoma s.c. on the thigh. p-Boronophenylalanine (BPA), a boronated analogue of natural melanin precursors, was used to target boron selectively to melanoma. BPA was administered to the mice either via i.p. injection or p.o. by intubation.
Coderre, J. A. +5 more
openaire +2 more sources
Side effects of boron neutron capture therapy
ABSTRACT Boron neutron capture therapy (BNCT) is an innovative cancer treatment modality that selectively eliminates tumor cells while sparing normal tissues. Clinical studies have explored its application across various malignancies, including malignant gliomas, meningiomas, pediatric tumors, head and neck cancers, and melanomas.
Yushu, Zhang, Yufeng, Cheng
openaire +2 more sources
Colautti P, Evangelista L, Fagotti E
openaire +4 more sources
This work provides the first experimental proof of an increased neutron capture photon signal following the introduction of boron to a PMMA phantom during helium and carbon ion therapies in Neutron Capture Enhanced Particle Therapy (NCEPT).
Marissa Kielly +13 more
doaj +1 more source
Boron neutron capture therapy of cancer: Recent progress
Li Zhao, Weilian Yang, Qing Lan
doaj +1 more source

